Clinical trial
Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance…
NCT00209209 · European Mantle Cell Lymphoma Network, Other · Unknown status
Key facts
| NCT number | NCT00209209 |
|---|---|
| Title | Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL |
| Official title | Efficacy of Maintenance Therapy With Rituximab After Induction Chemotherapy (R-CHOP vs. R-FC) for Elderly Patients With Mantle Cell Lymphoma Not Suitable for Autologous Stem Cell Transplantation |
| Acronym | MCLelderly |
| Lead sponsor | European Mantle Cell Lymphoma Network, Other |
| Collaborators | German Low Grade Lymphoma Study Group Lymphoma Study Association HOVON - Dutch Haemato-Oncology Association Nordic Lymphoma Group |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma, Mantle-Cell |
| Intervention type | Drug, Procedure |
| Interventions | Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Fludarabine, Interferon-alpha, pegylated formula Interferon-alpha 2b, chemotherapy: R-CHOP, chemotherapy: R-FC and 2 more |
| Enrollment | 570 |
| Start date | Jan 14, 2004 |
| Primary completion | Dec 1, 2018 |
| Completion | Dec 1, 2018 |
| First posted | Sep 21, 2005 |
| Last update posted | Mar 7, 2017 |
| Countries | Czechia, Denmark, France, Germany, Italy, Netherlands, Poland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: